Artal Group S.A., Director, 10% Owner at LEXICON PHARMACEUTICALS, INC. (LXRX), bought 23,938,462 shares at $1.30 ($31.1M) on 2026-02-02, disclosed to the SEC on 2026-02-04.
Open-market purchase of $31.1M LXRX by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.30 | 1,538,462 | $2.0M | 6.4% |
| 2 | $1.30 | 3,846,154 | $5.0M | 16.1% |
| 3 | $1.30 | 18,553,846 | $24.1M | 77.5% |
| Total | $1.30 avg | 23,938,462 | $31.1M | 100% |
| Filing → |
| LXRX | BUY | 2023-06-05 | $72.2M | — | Filing → |
| GLYC | BUY | 2023-02-23 | $711K | — | Filing → |
| SRRK | SELL | 2023-01-11 | $10K | — | Filing → |